Cansu Tol
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cansu Tol has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Hüsnü Pullukçu
Ege Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Izmir, Turkiye
4 shared publications - Meltem Ceylan
Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, İzmir, Turkiye
3 shared publications - Meltem Işıkgöz Taşbakan
Department of Infectious Diseases and Clinical Microbiology, Ege University Faculty of Medicine, Izmir, Türkiye
3 shared publications - Derya Kaya
Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, İzmir, Turkiye
2 shared publications - Adem Kaya
Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Karadeniz Technical University, 61080, Trabzon, Türkiye
1 shared publication - Ahmet Turan Koç
Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Karadeniz Technical University, 61080, Trabzon, Türkiye
1 shared publication
Latest Publications
- Open Access
- 30 May 2026
- Published by Springer Nature in Scientific Reports
Missed opportunities for HIV testing in hospitalised adults in türkiye: ındicator conditions and testing coverage in a national multicentre point-prevalence survey (HIV-ICs-TR)
To quantify the prevalence of HIV testing indications among hospitalised adults in Türkiye, assess HIV testing coverage when clinically indicated, and identify missed diagnostic opportunities in a national multicentre point-prevalence survey. We conducted a national multicentre cross-sectional point-prevalence survey across tertiary referral hospitals from all seven geographical regions of Türkiye. Adult inpatients present at 08:00 on a predefined index day were assessed for predefined HIV testing indications, including AIDS-defining conditions, indicator conditions associated with an expected undiagnosed HIV prevalence ≥ 0.1%, and conditions in which unrecognised HIV could substantially affect clinical management. Among 3,425 hospitalised adults without known HIV infection, 699 (20.4%) had at least one documented HIV testing indication. HIV testing was requested by the primary clinical team in 424/699 patients (60.7%). Testing was lowest in patients with indicator conditions associated with an expected undiagnosed HIV prevalence ≥ 0.1%, and these conditions were independently associated with higher odds of non-performance of HIV testing by the primary clinical team than AIDS-defining conditions (corresponding adjusted odds ratio [aOR] 3.05, 95% confidence interval [CI] 1.67–5.81). In centres with a specialised HIV outpatient clinic, the odds of non-performance of HIV testing by the primary clinical team were independently lower among patients with an appropriate testing indication (corresponding aOR 0.64, 95% CI 0.43–0.95). Following study-team facilitation, overall testing coverage increased to 677/699 (96.9%). Three reactive screening results were identified, including two confirmed new HIV diagnoses. HIV testing indications were common among hospitalised adults in Türkiye, but non-performance of HIV testing by the primary clinical team remained frequent, particularly for non-AIDS indicator conditions. Strengthening indicator-condition-guided testing through structured clinical pathways and institutional HIV expertise may reduce non-performance and support earlier HIV diagnosis.
- 30 May 2026
- Published by Springer Nature in Scientific Reports
Open AccessMissed opportunities for HIV testing in hospitalised adults in türkiye: ındicator conditions and testing coverage in a national multicentre point-prevalence survey (HIV-ICs-TR)
To quantify the prevalence of HIV testing indications among hospitalised adults in Türkiye, assess HIV testing coverage when clinically indicated, and identify missed diagnostic opportunities in a national multicentre point-prevalence survey. We conducted a national multicentre cross-sectional point-prevalence survey across tertiary referral hospitals from all seven geographical regions of Türkiye. Adult inpatients present at 08:00 on a predefined index day were assessed for predefined HIV testing indications, including AIDS-defining conditions, indicator conditions associated with an expected undiagnosed HIV prevalence ≥ 0.1%, and conditions in which unrecognised HIV could substantially affect clinical management. Among 3,425 hospitalised adults without known HIV infection, 699 (20.4%) had at least one documented HIV testing indication. HIV testing was requested by the primary clinical team in 424/699 patients (60.7%). Testing was lowest in patients with indicator conditions associated with an expected undiagnosed HIV prevalence ≥ 0.1%, and these conditions were independently associated with higher odds of non-performance of HIV testing by the primary clinical team than AIDS-defining conditions (corresponding adjusted odds ratio [aOR] 3.05, 95% confidence interval [CI] 1.67–5.81). In centres with a specialised HIV outpatient clinic, the odds of non-performance of HIV testing by the primary clinical team were independently lower among patients with an appropriate testing indication (corresponding aOR 0.64, 95% CI 0.43–0.95). Following study-team facilitation, overall testing coverage increased to 677/699 (96.9%). Three reactive screening results were identified, including two confirmed new HIV diagnoses. HIV testing indications were common among hospitalised adults in Türkiye, but non-performance of HIV testing by the primary clinical team remained frequent, particularly for non-AIDS indicator conditions. Strengthening indicator-condition-guided testing through structured clinical pathways and institutional HIV expertise may reduce non-performance and support earlier HIV diagnosis.
- 24 December 2025
- Published by Bilimsel Tip Publishing House in Flora the Journal of Infectious Diseases and Clinical Microbiology
- Vol. 30 (4) , 423-431
HIV ile Yaşayan Kişilerde Hepatit B ve Hepatit C Koinfeksiyonlarının Yönetimi: Rehber Önerilerine Uyuyor muyuz?
- 24 December 2025
- Published by Bilimsel Tip Publishing House in Flora the Journal of Infectious Diseases and Clinical Microbiology
- Vol. 30 (4) , 423-431
HIV ile Yaşayan Kişilerde Hepatit B ve Hepatit C Koinfeksiyonlarının Yönetimi: Rehber Önerilerine Uyuyor muyuz?
- 25 June 2024
- Published by Bilimsel Tip Publishing House in Flora the Journal of Infectious Diseases and Clinical Microbiology
- Vol. 29 (2) , 307-312
Tularemi: Tedavi Gecikmesi Nelere Neden Olur?
- 25 June 2024
- Published by Bilimsel Tip Publishing House in Flora the Journal of Infectious Diseases and Clinical Microbiology
- Vol. 29 (2) , 307-312
Tularemi: Tedavi Gecikmesi Nelere Neden Olur?
- Open Access
- 30 April 2024
- Published by Antibiyotik ve Kemoterapi Dernegi in ANKEM DERGİSİ
- Vol. 38 (1) , 24-29
NÖROSİFİLİZ: ÜÇ OLGU
“Büyük taklitçi” sifiliz, Treponema pallidum’un neden olduğu multisistemik tutulum yapan bir hastalıktır. Nörosifiliz, yani sifilizin santral sinir sistemi (SSS) tutulumu genellikle sekonder ve tersiyer evrelerinde görülmekle birlikte her evrede karşımıza çıkabilir. Artan sifiliz olgu sayılarına paralel olarak primer enfeksiyondan 4-10 yıl sonra tedavi edilmeyen veya yetersiz tedavi gören olgularda nörosifiliz riski de artmıştır. Bu nedenle nörolojik ve psikiyatrik bozuklukların ayırıcı tanısında akılda tutulması gereken bir hastalıktır. Nörolojik tutulumda motor ve duyusal etkilenme, oftalmik ve işitsel semptomlar, kranial sinir paralizileri, menenjit semptom ve bulguları görülebilir. Hastalığa bağlı oküler bulgular SSS tutulumunun önemli belirteçlerindendir. En sık görülen psikiyatrik bozukluklar ise demans, depresyon ve grandiyozitedir. Burada kliniğimizde nadir olarak karşılaştığımız ancak artan sayılarla birlikte 2023 yılında takip edilen, farklı nörolojik ve oküler bulgular ile başvurmuş olan üç nörosifiliz olgusu konuya dikkat çekmek amacı ile paylaşılmıştır.
- 30 April 2024
- Published by Antibiyotik ve Kemoterapi Dernegi in ANKEM DERGİSİ
- Vol. 38 (1) , 24-29
Open AccessNÖROSİFİLİZ: ÜÇ OLGU
“Büyük taklitçi” sifiliz, Treponema pallidum’un neden olduğu multisistemik tutulum yapan bir hastalıktır. Nörosifiliz, yani sifilizin santral sinir sistemi (SSS) tutulumu genellikle sekonder ve tersiyer evrelerinde görülmekle birlikte her evrede karşımıza çıkabilir. Artan sifiliz olgu sayılarına paralel olarak primer enfeksiyondan 4-10 yıl sonra tedavi edilmeyen veya yetersiz tedavi gören olgularda nörosifiliz riski de artmıştır. Bu nedenle nörolojik ve psikiyatrik bozuklukların ayırıcı tanısında akılda tutulması gereken bir hastalıktır. Nörolojik tutulumda motor ve duyusal etkilenme, oftalmik ve işitsel semptomlar, kranial sinir paralizileri, menenjit semptom ve bulguları görülebilir. Hastalığa bağlı oküler bulgular SSS tutulumunun önemli belirteçlerindendir. En sık görülen psikiyatrik bozukluklar ise demans, depresyon ve grandiyozitedir. Burada kliniğimizde nadir olarak karşılaştığımız ancak artan sayılarla birlikte 2023 yılında takip edilen, farklı nörolojik ve oküler bulgular ile başvurmuş olan üç nörosifiliz olgusu konuya dikkat çekmek amacı ile paylaşılmıştır.